rs2298240

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.4249+137G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.108 in 764,244 control chromosomes in the GnomAD database, including 5,111 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.088 ( 793 hom., cov: 33)
Exomes 𝑓: 0.11 ( 4318 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.311

Publications

2 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 13-110163326-C-G is Benign according to our data. Variant chr13-110163326-C-G is described in ClinVar as Benign. ClinVar VariationId is 1231553.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.125 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.4249+137G>C intron_variant Intron 47 of 51 ENST00000375820.10 NP_001836.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.4249+137G>C intron_variant Intron 47 of 51 1 NM_001845.6 ENSP00000364979.4

Frequencies

GnomAD3 genomes
AF:
0.0883
AC:
13433
AN:
152144
Hom.:
794
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0229
Gnomad AMI
AF:
0.0680
Gnomad AMR
AF:
0.0907
Gnomad ASJ
AF:
0.134
Gnomad EAS
AF:
0.0141
Gnomad SAS
AF:
0.120
Gnomad FIN
AF:
0.0966
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.127
Gnomad OTH
AF:
0.100
GnomAD4 exome
AF:
0.113
AC:
69083
AN:
611982
Hom.:
4318
AF XY:
0.115
AC XY:
37389
AN XY:
326444
show subpopulations
African (AFR)
AF:
0.0209
AC:
343
AN:
16426
American (AMR)
AF:
0.0758
AC:
2586
AN:
34098
Ashkenazi Jewish (ASJ)
AF:
0.124
AC:
2501
AN:
20100
East Asian (EAS)
AF:
0.0326
AC:
1049
AN:
32200
South Asian (SAS)
AF:
0.119
AC:
7444
AN:
62702
European-Finnish (FIN)
AF:
0.104
AC:
4985
AN:
48060
Middle Eastern (MID)
AF:
0.0567
AC:
234
AN:
4124
European-Non Finnish (NFE)
AF:
0.128
AC:
46470
AN:
362172
Other (OTH)
AF:
0.108
AC:
3471
AN:
32100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
3309
6617
9926
13234
16543
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
516
1032
1548
2064
2580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0882
AC:
13426
AN:
152262
Hom.:
793
Cov.:
33
AF XY:
0.0867
AC XY:
6452
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0228
AC:
947
AN:
41556
American (AMR)
AF:
0.0906
AC:
1385
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.134
AC:
465
AN:
3468
East Asian (EAS)
AF:
0.0141
AC:
73
AN:
5176
South Asian (SAS)
AF:
0.120
AC:
581
AN:
4828
European-Finnish (FIN)
AF:
0.0966
AC:
1024
AN:
10604
Middle Eastern (MID)
AF:
0.0952
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
0.127
AC:
8651
AN:
68016
Other (OTH)
AF:
0.0993
AC:
210
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
642
1284
1925
2567
3209
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0350
Hom.:
36
Bravo
AF:
0.0841
Asia WGS
AF:
0.0650
AC:
225
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
9.0
DANN
Benign
0.53
PhyloP100
0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2298240; hg19: chr13-110815673; API